Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
暂无分享,去创建一个
T. Roskams | D. van der Poorten | J. George | E. Bugianesi | C. Liddle | M. Komuta | M. Kacevska | Lindsay E. Wu | L. Hebbard | C. Samer | Mehdi Ramezani-Moghadam | S. Coulter | D. Mcleod | D. Schrijnders | D. K. van der Poorten | D. McLeod | Sally Coulter
[1] M. Manns,et al. Zakim and Boyer's hepatology , 2012 .
[2] J. Chiang,et al. Bile Acid Signaling in Liver Metabolism and Diseases , 2011, Journal of lipids.
[3] B. Neuschwander‐Tetri,et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.
[4] T. Salman,et al. Study of adiponectin in chronic liver disease and cholestasis , 2010, Hepatology international.
[5] J. Hardies,et al. Pioglitazone in the treatment of NASH: the role of adiponectin , 2010, Alimentary pharmacology & therapeutics.
[6] J. Dufour,et al. Significance of serum adiponectin levels in patients with chronic liver disease , 2010, Clinical science.
[7] William M. Lee,et al. Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long‐term treatment against cirrhosis (HALT‐C) trial , 2009, Hepatology.
[8] A. Floreani,et al. Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis , 2008, The American Journal of Gastroenterology.
[9] R. Cardiff,et al. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. , 2008, Cancer research.
[10] J. Luk,et al. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. , 2007, Journal of hepatology.
[11] S. Fiorucci,et al. The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo , 2006, Molecular Pharmacology.
[12] G. Zoppini,et al. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease , 2006, Clinical endocrinology.
[13] Folkert Kuipers,et al. The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice* , 2006, Journal of Biological Chemistry.
[14] F. Anania,et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. , 2005, The American journal of pathology.
[15] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[16] T. Luedde,et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. , 2005, Journal of hepatology.
[17] E. Fassio,et al. Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies , 2004, Hepatology.
[18] M. Manns,et al. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. , 2004, American journal of physiology. Endocrinology and metabolism.
[19] S. Caldwell,et al. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. , 2004, Journal of hepatology.
[20] T. Roskams,et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease , 2004, Hepatology.
[21] James G Kench,et al. Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.
[22] Yu Wang,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.
[23] Masataka Harada,et al. A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.
[24] M. Stumvoll,et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. , 2003, Diabetes.
[25] J. Pomposelli,et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. , 2002, Human pathology.
[26] R. Fisher,et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[28] A. McCullough,et al. Effect of cirrhosis on energy expenditure. , 1999, The American journal of clinical nutrition.
[29] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[30] A. West,et al. Noninvasive assessment of hepatic triglyceride content in humans with 13C nuclear magnetic resonance spectroscopy , 1996, Hepatology.
[31] O. Matsui,et al. Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. , 1995, AJR. American journal of roentgenology.
[32] J. Ludwig,et al. Two cases from the spectrum of nonalcoholic steatohepatitis. , 1995, Journal of clinical gastroenterology.
[33] R. Hanson,et al. The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.
[34] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[35] A. Avogaro,et al. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. , 1984, The Journal of clinical endocrinology and metabolism.
[36] H. Popper,et al. Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.
[37] G. Van den Berghe,et al. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression , 2011, Hepatology.
[38] N. Samy,et al. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4. , 2010, Clinical laboratory.
[39] B. Staels,et al. Role of bile acids and bile acid receptors in metabolic regulation. , 2009, Physiological reviews.
[40] E. Brunt. Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.
[41] C. González Hernández,et al. [Cryptogenic cirrhosis?]. , 1999, Anales de medicina interna.